This evolution is taking place alongside a broader redefinition of healthcare delivery itself
Stomach or gastrointestinal side effects are common, but they tend to be mild and clear up in a few weeks and usually will not interfere with long-term treatment
While recent randomized clinical trials have rightly generated a lot of interest in GLP-1 agonists, having these results, specifically reduction in the composite outcome of heart failure hospitalizations and all-cause mortality, replicated in a large cohort study will likely increase their utilization even before we see a change in guidelines, she told Healthline
However, with appropriate dose adjustment and consistent use, oral formulations can support meaningful clinical response for many patients
A new study published on March 3 in Cell Metabolism found that GLP-1 drugs like Ozempic and Wegovy, which contain the active ingredient semaglutide, can help ease the effects of osteoarthritis on joints